Phase II Study of Treatment Selection Based Upon Tumor Thymidylate Synthase Expression in Previously Untreated Patients with Metastatic Colorectal Cancer: A Trial of the ECOG-ACRIN...

par Meropol, Neal J., Feng, Yang, Grem, Jean L., Mulcahy, Mary F., Catalano, Paul J., Kauh, John S., Hall, Michael J., Saltzman, Joel N., George, Thomas J., Zangmeister, Jeffrey, Chiorean, Elena G., Cheema, Puneet S., O’Dwyer, Peter J., Benson, Al B.
Publié dans Cancer (2017)

A 3-Arm Randomized Phase II Study of Bendamustine/Rituximab with Bortezomib Induction or Lenalidomide Continuation in Untreated Follicular Lymphoma: ECOG-ACRIN E2408

par Evens, Andrew M., Hong, Fangxin, Habermann, Thomas M., Advani, Ranjana H., Gascoyne, Randy D., Witzig, Thomas E., Quon, Andrew, Ranheim, Erik, Ansell, Stephen M., Cheema, Puneet Singh, Dy, Philip A., O’Brien, Timothy E., Winter, Jane N., Cescon, Terrence P., Chang, Julie E., Kahl, Brad S.
Publié dans Clin Cancer Res (2020)

Lenalidomide-Epoetin Alfa Versus Lenalidomide Monotherapy in Myelodysplastic Syndromes Refractory to Recombinant Erythropoietin

par List, Alan F., Sun, Zhuoxin, Verma, Amit, Bennett, John M., Komrokji, Rami S., McGraw, Kathy, Maciejewski, Jaroslaw, Altman, Jessica K., Cheema, Puneet S., Claxton, David F., Luger, Selina M., Mattison, Ryan J., Wassenaar, Timothy R., Artz, Andrew S., Schiffer, Charles A., Litzow, Mark R., Tallman, Martin S.
Publié dans J Clin Oncol (2021)

Randomized Phase II Trial of Fulvestrant Plus Everolimus or Placebo in Postmenopausal Women With Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Metast...

par Kornblum, Noah, Zhao, Fengmin, Manola, Judith, Klein, Paula, Ramaswamy, Bhuvaneswari, Brufsky, Adam, Stella, Phillip J., Burnette, Brian, Telli, Melinda, Makower, Della F., Cheema, Puneet, Truica, Cristina I., Wolff, Antonio C., Soori, Gamini S., Haley, Barbara, Wassenaar, Timothy R., Goldstein, Lori J., Miller, Kathy D., Sparano, Joseph A.
Publié dans J Clin Oncol (2018)